Power Heated Seat Pkg,sport Classic Wheels,hardtop,original & Well Kept Cab! on 2040-cars

Auto blog

Porsche recalling Macan S and Turbo for fuel leak

Porsche is recalling 58,881 examples of the Macan S and Turbo worldwide because of a possible leak in the low-pressure fuel line in the engine compartment. Of these, there are 21,835 affected in the US and 3,490 in Canada. According to the German automaker, this campaign is "a purely precautionary measure" because there're no reports of any accidents or injuries from the flaw. As a fix, dealers will replace the fuel line, which will take around an hour. Porsche will contact owners directly to arrange for the service. The company discovered the issue "after a precise examination of complaints," according to its statement, and corrected the problem for units in production. Porsche Examines Macan S and Macan Turbo Vehicles October 30, 2015 Possible leak in low-pressure line – affected customers will be contacted directly Atlanta, Georgia. Voluntary safety recall: Porsche is conducting an examination of 58,881 Macan S and Macan Turbo vehicles around the world, of which 21,835 are in the United States and 3,490 are in Canada. The reason for this move is a possible leak in the low-pressure fuel line inside the engine compartment. The line will be replaced in the workshop. This is a purely precautionary measure, as there have been no reports of accidents or injuries as a result of this concern. The problem was identified after a precise examination of complaints and then immediately rectified in ongoing production. Owners of the vehicles will be contacted directly and workshop appointments will be arranged as quickly as possible. The work will take approximately one hour and will be carried out free of charge.

Porsche finally moving ahead with flat four engine

When Porsche released the first Boxster in 1996 and the first Cayman in 2005, the idea was to create an entry-level model for the German automaker's sports car range. The latest iterations of both closely related models, however, have begun to encroach dangerously on the 911's territory, particularly in their newest GTS specifications. That could be about to change, however, with the introduction of a four-cylinder engine for the compact mid-engined coupe and roadster.
According to Automotive News, Porsche is finally preparing to launch a new boxer four engine in the Boxster and Cayman, following years of speculation. The engine would be based on the same architecture as the company's famous flat six, but with two fewer cylinders to cut weight. Don't expect it to cut much in the way of performance, however: Porsche chief Matthias Muller indicates that the new engine could produce as much as 395 horsepower - significantly more than even the 340hp flat six in the Cayman GTS, suggesting that the engine could even find its way into the 911 as well.
It's no more clear which markets would get the four-cylinder engine, either. But wherever it is offered and in whichever form, it wouldn't be the first time we'd see a Porsche with a four-pot engine. Not by a long shot. Both the classic 912 and 356 were powered by boxer fours, as was the 914 - not to mention the 718 pictured above and the iconic 550 Spyder. The front-engined 924, 944 and 968 packed inline-four engines, but the last of those were discontinued in the 1990s. The prospect of a four-cylinder Boxster/Cayman has been rumored for many years now, most recently joined by the possibility of a four-pot Macan as well.

Porsche suspends ties with Maria Sharapova after drug test

Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video: